CAS: 162011-90-7 - Rofecoxib
Formula:C17H14O4S
InChI:InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3
InChI key:InChIKey=RZJQGNCSTQAWON-UHFFFAOYSA-N
SMILES:O=C1OCC(C=2C=CC(=CC2)S(=O)(=O)C)=C1C=3C=CC=CC3
- Synonyms:
- 2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-
- 3-(4-Methanesulfonylphenyl)-2-phenyl-2-buten-4-olide
- 3-Phenyl-4-[4-(Methylsulfonyl)phenyl]-2(5H)-furanone
- 4-(4-(Methanesulfonyl)phenyl)-3-phenyl-5H-furan-2-one
- 4-[4-(Methylsulfonyl)-phenyl]-3-phenyl-2(5H)-furanone
- 4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
- Ceeoxx
- Ceoxx
- Mk 0966
- Mk 966
- See more synonyms
- Rhuma-cure
- Romacox
- Vioxx
Rofecoxib
CAS:162011-90-7
Formula:
C17H14O4S
Purity:
>98.0%(GC)
Color and Shape:
White to Yellow to Orange powder to crystal
Molecular weight:
314.36
- Anti-inflammatory
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Enzyme Activators and Inhibitors
- Enzymes
- See more categories
- Immunology and Inflammation
- Cyclooxygenase (COX) Inhibitors
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Biochemicals and Reagents
- Cellular and Molecular Biology
Ref: 3B-R0206
| 1g | 185.00 € | |
| 250mg | 66.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
![2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-](https://static.cymitquimica.com/products/AN/thumb/AG001SMS.jpg)
2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-
CAS:162011-90-7
Formula:
C17H14O4S
Purity:
99%;RG
Color and Shape:
Solid
Molecular weight:
314.3557
- Anti-inflammatory
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Enzyme Activators and Inhibitors
- Active Pharmaceutical Ingredients (API) for research
- See more categories
- Enzymes
- Immunology and Inflammation
- Cyclooxygenase (COX) Inhibitors
- Other Inhibitors
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Biochemicals and Reagents
- Cellular and Molecular Biology
Ref: AN-AG001SMS
| 1g | 124.00 € | |
| 5g | 306.00 € | |
| 25g | 1,027.00 € | |
| 100mg | 56.00 € | |
| 250mg | 66.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Rofecoxib
CAS:162011-90-7
Rofecoxib (MK 966) binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in an inhibition …
Formula:
C17H14O4S
Purity:
99.94%
Color and Shape:
Off-White (Pale Yellow) Crystalline Powder
Molecular weight:
314.36
Ref: TM-T1185
| 50mg | 45.00 € | |
| 100mg | 54.00 € | |
| 200mg | 67.00 € | |
| 1ml*10 (DMSO) | 54.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Ref: 4Z-R-751
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
Rofecoxib
CAS:162011-90-7
Formula:
C17H14O4S
Purity:
≥ 99.0%
Color and Shape:
Yellow crystalline powder
Molecular weight:
314.36
Ref: 7W-GP0159
| 10mg | 35.00 € | |
| 50mg | 70.00 € | |
| 100mg | 111.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Vioxx
Controlled ProductCAS:162011-90-7
Applications A selective cyclooxygenase-2 (COX-2) inhibitor. Use as an anti-inflammatory, analgesic. References Catalla-Lawson, F., et …
Formula:
C17H14O4S
Color and Shape:
White to Off-White Solid
Molecular weight:
314.36
Ref: TR-V670000
| 10mg | 80.00 € | |
| 100mg | 164.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Rofecoxib - Bio-X ™
Controlled ProductCAS:162011-90-7
Rofecoxib is a non-steroidal anti-inflammatory drug that is used to treat osteoarthritis, acute pain and …
Formula:
C17H14O4S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
314.36 g/mol
Ref: 3D-BR164362
| 100mg | 116.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Rofecoxib
Controlled ProductCAS:162011-90-7
COX-2 inhibitor; a non-steroidal anti-inflammatory drug
Formula:
C17H14O4S
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
314.36 g/mol
Ref: 3D-FV28711
| 1g | 457.00 € | |
| 2g | 669.00 € | |
| 5g | 968.00 € | |
| 250mg | 179.00 € | |
| 500mg | 286.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
